37. 有關於 phosphodiesterase4(PDE4)inhibitors 的藥物用於 COPD 治療,下列何者為非 :
(A) By its mechanism, PDE4 inhibitors decrease airway inflammation and have direct
bronchodilator activity.
(B) PDE4 inhibitors has been approved for patients with severe to very severe COPD patients
and frequent exacerbations.
(C) Guidelines recommend that PDE4 inhibitors be used in combination with a long acting
bronchodilators
(D) Monitoring weight during treatment is warranted.
詳解 (共 2 筆)
未解鎖
有關 phosphodiesterase...
未解鎖
你好!這是一道關於 COPD(慢性阻塞性...